Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 31

1.

Blue Genes? Understanding and Mitigating Negative Consequences of Personalized Information about Genetic Risk for Depression.

Lebowitz MS, Ahn WK.

J Genet Couns. 2018 Feb;27(1):204-216. doi: 10.1007/s10897-017-0140-5. Epub 2017 Aug 7.

PMID:
28785835
2.

Preferences for the provision of whole genome sequencing services among young adults.

Wade CH, Elliott KR.

PLoS One. 2017 Mar 23;12(3):e0174131. doi: 10.1371/journal.pone.0174131. eCollection 2017.

3.

A Qualitative Study of Anticipated Decision Making around Type 2 Diabetes Genetic Testing: the Role of Scientifically Concordant and Discordant Expectations.

Carmichael AG, Hulswit BB, Moe EJ, Jayaratne TE, Yashar BM.

J Genet Couns. 2017 Jun;26(3):469-479. doi: 10.1007/s10897-016-9999-9. Epub 2016 Jul 28.

PMID:
27465809
5.

Lessons from HeLa Cells: The Ethics and Policy of Biospecimens.

Beskow LM.

Annu Rev Genomics Hum Genet. 2016 Aug 31;17:395-417. doi: 10.1146/annurev-genom-083115-022536. Epub 2016 Mar 3. Review.

6.

Using the scenario method in the context of health and health care--a scoping review.

Vollmar HC, Ostermann T, Redaèlli M.

BMC Med Res Methodol. 2015 Oct 16;15:89. doi: 10.1186/s12874-015-0083-1. Review.

7.

Development and preliminary evaluation of an online educational video about whole-genome sequencing for research participants, patients, and the general public.

Sanderson SC, Suckiel SA, Zweig M, Bottinger EP, Jabs EW, Richardson LD.

Genet Med. 2016 May;18(5):501-12. doi: 10.1038/gim.2015.118. Epub 2015 Sep 3.

8.

What Matters to Women When Making Decisions About Breast Cancer Chemoprevention?

Martinez KA, Fagerlin A, Witteman HO, Holmberg C, Hawley ST.

Patient. 2016 Apr;9(2):149-59. doi: 10.1007/s40271-015-0134-z.

9.

Effects of racial and ethnic group and health literacy on responses to genomic risk information in a medically underserved population.

Kaphingst KA, Stafford JD, McGowan LD, Seo J, Lachance CR, Goodman MS.

Health Psychol. 2015 Feb;34(2):101-10. doi: 10.1037/hea0000177.

10.

Genetic literacy and patient perceptions of IBD testing utility and disease control: a randomized vignette study of genetic testing.

Hooker GW, Peay H, Erby L, Bayless T, Biesecker BB, Roter DL.

Inflamm Bowel Dis. 2014 May;20(5):901-8. doi: 10.1097/MIB.0000000000000021.

11.

Growing up in the genomic era: implications of whole-genome sequencing for children, families, and pediatric practice.

Wade CH, Tarini BA, Wilfond BS.

Annu Rev Genomics Hum Genet. 2013;14:535-55. doi: 10.1146/annurev-genom-091212-153425. Epub 2013 Jul 15. Review.

12.

Incorporating direct-to-consumer genomic information into patient care: attitudes and experiences of primary care physicians.

Bernhardt BA, Zayac C, Gordon ES, Wawak L, Pyeritz RE, Gollust SE.

Per Med. 2012 Sep 1;9(7):683-692.

13.

'Information is information': a public perspective on incidental findings in clinical and research genome-based testing.

Daack-Hirsch S, Driessnack M, Hanish A, Johnson VA, Shah LL, Simon CM, Williams JK.

Clin Genet. 2013 Jul;84(1):11-8. doi: 10.1111/cge.12167. Epub 2013 May 3.

14.

Redeeming qualities: exploring factors that affect women's use of reproductive health vouchers in Cambodia.

Brody CD, Freccero J, Brindis CD, Bellows B.

BMC Int Health Hum Rights. 2013 Feb 26;13:13. doi: 10.1186/1472-698X-13-13.

15.

Genetic susceptibility testing for chronic disease and intention for behavior change in healthy young adults.

Vassy JL, Donelan K, Hivert MF, Green RC, Grant RW.

J Community Genet. 2013 Apr;4(2):263-71. doi: 10.1007/s12687-013-0140-6. Epub 2013 Feb 24.

16.

Interpretation of melanoma risk feedback in first-degree relatives of melanoma patients.

Hay JL, Baguer C, Li Y, Orlow I, Berwick M.

J Cancer Epidemiol. 2012;2012:374842. doi: 10.1155/2012/374842. Epub 2012 Jul 25.

17.

Public perspectives about pharmacogenetic testing and managing ancillary findings.

Haga SB, Tindall G, O'Daniel JM.

Genet Test Mol Biomarkers. 2012 Mar;16(3):193-7. doi: 10.1089/gtmb.2011.0118. Epub 2011 Nov 2.

18.

Professional perspectives about pharmacogenetic testing and managing ancillary findings.

Haga SB, Tindall G, O'Daniel JM.

Genet Test Mol Biomarkers. 2012 Jan;16(1):21-4. doi: 10.1089/gtmb.2011.0045. Epub 2011 Jul 19.

19.

Public attitudes toward ancillary information revealed by pharmacogenetic testing under limited information conditions.

Haga SB, O'Daniel JM, Tindall GM, Lipkus IR, Agans R.

Genet Med. 2011 Aug;13(8):723-8. doi: 10.1097/GIM.0b013e31821afcc0.

20.

Public perspectives on returning genetics and genomics research results.

O'Daniel J, Haga SB.

Public Health Genomics. 2011;14(6):346-55. doi: 10.1159/000324933. Epub 2011 May 7.

Supplemental Content

Support Center